Synonyms: CAD-1883 | CAD1883 | compound 1 [US9975886B1]
Compound class:
Synthetic organic
Comment: Rimtuzalcap (CAD-1883) is a KCa2 channel activator (positive allosteric modulator) [1], that was developed for potential to treat movement disorders such as essential tremor and spinocerebellar ataxia.
|
|
References |
1. Amrutkar DVm Foster K, Jacobsen TA, Jefson MR, Keaney GF, Larsen JS, Nielsen KS. (2018)
Potassium channel modulators. Patent number: US9975886B1. Assignee: Cadent Therapeutics Inc. Priority date: 23/01/2018. Publication date: 22/04/2018. |